Search

everythinglearnresearchcommunity

for

Search:↓

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Integrative hair therapy improved hair loss and regrowth.

Laser therapy is effective for treating vascular lesions with the right light settings and trained professionals.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Genetically modified cells improved skin wound healing in rats.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Targeting Vδ1+T-cells may help treat alopecia areata.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

UVA exposure worsens hair loss by activating a specific cell pathway.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

Valproic acid and rapamycin protect hair follicle stem cells from damage by activating a protective pathway.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.